Results 161 to 170 of about 421,015 (288)

A study of the effects of self-evaluation using a performance evaluation tool on learning a psychomotor skill

, 2010
Mary Fewster
openalex   +1 more source

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

The effect of balance exercises and computerized cognitive training on psychomotor performance in elderly. [PDF]

J Phys Ther Sci, 2017
Taheri M, Irandoust K.
europepmc   +1 more source

Repeated‐dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance [PDF]

, 2005
Eef L. Theunissen, Annemiek Vermeeren, Johannes G. Ramaekers   +2 more
openalex   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

British Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen, Declan P. McKernan, John P. Kelly   +2 more
wiley   +1 more source

Shift rotation, circadian misalignment and excessive body weight influence psychomotor performance: a prospective and observational study under real life conditions. [PDF]

Sci Rep, 2019
Rosa DE, Marot LP, de Mello MT, Narciso FV, Gonçalves BDSB, Marqueze EC, Crispim CA.   +6 more
europepmc   +1 more source

Cumulative Sleepiness, Mood Disturbance, and Psychomotor Vigilance Performance Decrements During a Week of Sleep Restricted to 4–5 Hours per Night [PDF]

, 1997
David F. Dinges, Frances M. Pack, Katherine Williams, Kelly A. Gillen, John W. Powell, Geoffrey E. Ott, Caitlin Aptowicz, Allan I Pack   +7 more
openalex   +1 more source

Portrait of a Spectrum: Clinical and Genetic Characterization of a Large Cohort of Chromatinopathies—30 Years' Experience From a Third Level Center

Clinical Genetics, EarlyView.
Chromatinopathies (CP) are a growing group of rare genetic disorders characterized by cognitive deficits and growth abnormalities. This is the largest collection of CP to date, contributing to a deeper understanding of the landscape and diagnosis of these rare diseases, strongly improved by the use of large‐scale sequencing technologies.
Giulia Bruna Marchetti, Erica Rosina, Camilla Meossi, Michela Mura, Lidia Pezzani, Angelo Selicorni, Maria Francesca Bedeschi, Romano Tenconi, Carlo Agostoni, Palma Finelli, Sara De Matteis, Elisabetta Di Fede, Valentina Massa, Laura Pezzoli, Cristina Gervasini, Maria Iascone, Donatella Milani   +16 more
wiley   +1 more source

Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. [PDF]

J Int Soc Sports Nutr, 2017
Marcus L, Soileau J, Judge LW, Bellar D.
europepmc   +1 more source

Dialectical Behavior Therapy and Cognitive Behavior Therapy in Individuals With Binge‐Eating Disorder: What Works for Whom?

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective To evaluate moderators and predictors of response to cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) for binge‐eating disorder (BED). Method Moderators/predictors of treatment outcome, central to CBT and to DBT treatment, were chosen from an aggregated dataset of two clinical outcome studies with non‐random ...
Mirjam W. Lammers, Maartje S. Vroling, Ross D. Crosby, Suzanne H. W. Mares, Giel J. M. Hutschemaekers, Tatjana Van Strien   +5 more
wiley   +1 more source